The latest news from academia, regulators
research labs and other things of interest
Posted: Sep 28, 2010
NanoViricides President Invited on the NanoMedicine Panel at NanoBusiness2010
(Nanowerk News) NanoViricides, Inc. announced today that Anil Diwan, PhD, President of the Company has been invited to participate in a panel discussion on nanomedicines development at the NanoBusiness2010. This event is taking place today at 2pm CDT at the 9th annual NanoBusiness Conference, held at the McCormick Place in Chicago, IL.
The panel, entitled "NanoMedicine: Science, Business and Regulatory Perspectives," is composed of experts from Industry, Government, and Academia. It is chaired and moderated by Dr. Mostafa Analoui, Head of HealthCare and Life Sciences at the Livingston Securities, NY. Dr. Diwan will discuss the current developments at NanoViricides, Inc., and the opportunities and challenges in bringing our nanoviricideŽ drugs to market.
This is the 9th annual conference on the business of nanotechnology organized by the NanoBusiness Alliance. The NanoBusiness Alliance mission is to create a collective voice for the advancing nanotechnology industry and develop a range of initiatives to support the nanotechnology business community.
NanoViricides, Inc. (www.nanoviricides.com) is a development stage company that is creating special purpose nanomaterials for viral therapy. The Company's novel nanoviricideŽ class of drug candidates are designed to specifically attack enveloped virus particles and to dismantle them. The Company is developing drugs against a number of viral diseases including H1N1 swine flu, H5N1 bird flu, seasonal Influenza, HIV, oral and genital herpes, viral diseases of the eye including EKC and herpes keratitis, Hepatitis C, Dengue fever, Rabies and Ebola virus, among others.